Teriparatide 750mcg/3mL (250mcg/mL) Injection

Teriparatide 750mcg/3mL (250mcg/mL) is an anabolic osteoporosis medicine for people at high risk of fracture. It stimulates new bone formation rather than only slowing bone loss.
Inject the metered 20mcg dose under the skin of the thigh or abdomen once daily using the pen device. Rotate injection sites. Use the first few doses where you can sit or lie down if dizziness occurs; never inject the full cartridge contents as a dose.
Intermittent exposure to a parathyroid-hormone fragment stimulates osteoblast activity and new bone formation.
Nausea, leg cramps, dizziness, injection-site discomfort and temporary increases in blood calcium can occur.
High calcium, Paget’s disease, bone malignancy, skeletal radiation or unexplained raised alkaline phosphatase affect suitability. Treatment duration and subsequent bone-protective therapy form part of the osteoporosis plan.
Increasing new bone formation can improve bone strength and reduce vertebral and other fracture risk in suitable high-risk patients.
No. Teriparatide primarily stimulates formation of new bone, while those medicines mainly reduce bone resorption.
Use the missed dose when remembered on the same day. If that day has already passed, skip it and resume the usual daily schedule. Never inject more than one dose in a day.
An antiresorptive medicine can help retain bone gained during the anabolic treatment course.
Adequate calcium and vitamin D support bone formation. Food and drink may supply enough, but a supplement can be needed when dietary intake is insufficient. High blood calcium or a kidney-stone history affects the amount suitable for you.
Osteoblast: a cell that forms bone. Anabolic bone treatment: treatment that stimulates bone formation. Parathyroid hormone: a hormone involved in calcium and bone regulation.; AR: Teriparatide 750mcg/3mL (250mcg/mL) حقن; FR: Teriparatide 750mcg/3mL (250mcg/mL) injection; PT: Teriparatide 750mcg/3mL (250mcg/mL) injeção; ES: Teriparatide 750mcg/3mL (250mcg/mL) inyección; RU: Teriparatide 750mcg/3mL (250mcg/mL) инъекция; ID: Teriparatide 750mcg/3mL (250mcg/mL) suntikan; VI: Teriparatide 750mcg/3mL (250mcg/mL) thuốc tiêm; MS: Teriparatide 750mcg/3mL (250mcg/mL) suntikan; TL: Teriparatide 750mcg/3mL (250mcg/mL) iniksyon; ZH-SG: Teriparatide 750mcg/3mL (250mcg/mL) 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Teriparatide 750mcg/3mL (250mcg/mL) Injection under Bone Health. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Teriparatide 750mcg/3mL (250mcg/mL) Injection